NUTEX HEALTH INC. (NUTX) FY2026 YTD Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
NUTEX HEALTH INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $109,718,000.00Net income → Operating adjustments reconciliation: $49,362,000.00Increase/(Decrease) in Accrued arbitration expenses → Operating adjustments reconciliation: $14,729,000.00Depreciation and amortization → Operating adjustments reconciliation: $10,809,000.00(Increase)/Decrease in Prepaid expenses and other current assets → Operating adjustments reconciliation: $4,122,000.00Increase/(Decrease) in Accrued expenses and other current liabilities → Operating adjustments reconciliation: $3,408,000.00Increase/(Decrease) in Accrued income tax expense → Operating adjustments reconciliation: $3,139,000.00Increase/(Decrease) in Accounts payable - Related Party → Operating adjustments reconciliation: $2,575,000.00Changes to deferred taxes → Operating adjustments reconciliation: $1,775,000.00(Increase)/Decrease in Accounts receivable - Related Party → Operating adjustments reconciliation: $953,000.00(Increase)/Decrease in Operating right-of-use assets → Operating adjustments reconciliation: $805,000.00Debt accretion expense → Operating adjustments reconciliation: $44,000.00Operating adjustments reconciliation → Non-cash effect of change in estimate: $52,319,000.00Operating adjustments reconciliation → (Increase)/Decrease in Accounts receivable - Nonrelated Party: $32,235,000.00Operating adjustments reconciliation → Increase/(Decrease) in Accounts payable - Nonrelated Party: $4,067,000.00Operating adjustments reconciliation → (Increase)/Decrease in Inventories: $1,341,000.00Operating adjustments reconciliation → Stock-based compensation expense: $1,031,000.00Operating adjustments reconciliation → Increase/(Decrease) in Operating lease liabilities: $728,000.00Net cash used in investing activities → investing reconciliation: $3,741,000.00investing reconciliation → Acquisitions of property and equipment: $3,741,000.00Net cash used in financing activities → financing reconciliation: $84,740,000.00Members' contributions → financing reconciliation: $1,405,000.00Proceeds from exercise of warrants → financing reconciliation: $75,000.00financing reconciliation → Cash related to stock repurchases and retirements: $50,688,000.00financing reconciliation → Members' distributions: $28,620,000.00financing reconciliation → Repayments of finance leases: $3,317,000.00financing reconciliation → Repayments of notes payable: $2,953,000.00financing reconciliation → Repayments of lines of credit: $642,000.00Difference in the filed cash totals (calculated) → Cash sources and uses: $297,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $185,574,000.00Net cash from operating activities → Cash sources and uses: $109,718,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $207,108,000.00Cash sources and uses → Net cash used in investing activities: $3,741,000.00Cash sources and uses → Net cash used in financing activities: $84,740,000.00Net income: $159,080,000.00Net income+$159.08 MDepreciation and amortization: $10,809,000.00Depreciation & amortization+$10.81 MStock-based compensation expense: -$1,031,000.00Noncash employee benefits−$1.03 MChanges to deferred taxes: $1,775,000.00Deferred income taxes+$1.78 MDebt accretion expense: $44,000.00Accretion expense+$44.00 KNon-cash effect of change in estimate: -$52,319,000.00Lease termination gain & loss−$52.32 M(Increase)/Decrease in Accounts receivable - Nonrelated Party: -$32,235,000.00Receivables: nonrelated party−$32.24 M(Increase)/Decrease in Accounts receivable - Related Party: $953,000.00Receivables: related party+$953.00 K(Increase)/Decrease in Inventories: -$1,341,000.00Inventories−$1.34 M(Increase)/Decrease in Prepaid expenses and other current assets: $4,122,000.00Prepaid & other assets+$4.12 M(Increase)/Decrease in Operating right-of-use assets: $805,000.00Operating lease amortization+$805.00 KIncrease/(Decrease) in Accounts payable - Nonrelated Party: -$4,067,000.00Payables: nonrelated party−$4.07 MIncrease/(Decrease) in Accounts payable - Related Party: $2,575,000.00Payables: related party+$2.58 MIncrease/(Decrease) in Operating lease liabilities: -$728,000.00Operating lease liabilities−$728.00 KIncrease/(Decrease) in Accrued arbitration expenses: $14,729,000.00Accrued arbitration expenses+$14.73 MIncrease/(Decrease) in Accrued income tax expense: $3,139,000.00Accrued taxes+$3.14 MIncrease/(Decrease) in Accrued expenses and other current liabilities: $3,408,000.00Other current liabilities+$3.41 MNet cash from operating activities: $109,718,000.00Operating cash+$109.72 MOperating adjustments reconciliation: $91,721,000.00Proceeds from lines of credit: $0.00Proceeds from notes payable: $0.00Repayments of lines of credit: -$642,000.00Credit line repayments−$642.00 KRepayments of notes payable: -$2,953,000.00Notes payable repaid−$2.95 MRepayments of finance leases: -$3,317,000.00Finance lease payments−$3.32 MCash related to stock repurchases and retirements: -$50,688,000.00Common stock repurchases−$50.69 MMembers' contributions: $1,405,000.00Members' contributions+$1.41 MMembers' distributions: -$28,620,000.00Members' distributions−$28.62 MProceeds from exercise of warrants: $75,000.00Warrant exercises+$75.00 KNet cash used in financing activities: -$84,740,000.00. Cash required to fund net payments.Financing cash−$84.74 Mfinancing reconciliation: $86,220,000.00Proceeds from restricted short-term investment: $0.00Cash related to asset acquisition: $0.00Acquisitions of property and equipment: -$3,741,000.00PP&E purchases−$3.74 MNet cash used in investing activities: -$3,741,000.00. Cash required to fund net payments.Investing cash−$3.74 Minvesting reconciliation: $3,741,000.00Cash sources and uses: $295,589,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $185,574,000.00Beginning cash$185.57 MEnding cash: Cash, cash equivalents, and restricted cash: $207,108,000.00Ending cash$207.11 MDifference in the filed cash totals (calculated): $297,000.00Filer's cash difference(calculated)+$297.00 KCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$105.98 MOperating cash − cash spent on PP&ECash flow / Net income0.69×Operating cash flow ÷ net incomeNet cash change+$21.53 MEnding cash − beginning cash
Chart details

NUTEX HEALTH INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
185,574,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
109,718,000 US dollars. Net cash provided.
Net income
159,080,000 US dollars
Depreciation and amortization
10,809,000 US dollars
Stock-based compensation expense
negative 1,031,000 US dollars
Changes to deferred taxes
1,775,000 US dollars
Debt accretion expense
44,000 US dollars
Non-cash effect of change in estimate
negative 52,319,000 US dollars
(Increase)/Decrease in Accounts receivable - Nonrelated Party
negative 32,235,000 US dollars
(Increase)/Decrease in Accounts receivable - Related Party
953,000 US dollars
(Increase)/Decrease in Inventories
negative 1,341,000 US dollars
(Increase)/Decrease in Prepaid expenses and other current assets
4,122,000 US dollars
(Increase)/Decrease in Operating right-of-use assets
805,000 US dollars
Increase/(Decrease) in Accounts payable - Nonrelated Party
negative 4,067,000 US dollars
Increase/(Decrease) in Accounts payable - Related Party
2,575,000 US dollars
Increase/(Decrease) in Operating lease liabilities
negative 728,000 US dollars
Increase/(Decrease) in Accrued arbitration expenses
14,729,000 US dollars
Increase/(Decrease) in Accrued income tax expense
3,139,000 US dollars
Increase/(Decrease) in Accrued expenses and other current liabilities
3,408,000 US dollars
Investing activities
negative 3,741,000 US dollars. Net cash used.
Proceeds from restricted short-term investment
0 US dollars
Cash related to asset acquisition
0 US dollars
Acquisitions of property and equipment
negative 3,741,000 US dollars
Financing activities
negative 84,740,000 US dollars. Net cash used.
Proceeds from lines of credit
0 US dollars
Proceeds from notes payable
0 US dollars
Repayments of lines of credit
negative 642,000 US dollars
Repayments of notes payable
negative 2,953,000 US dollars
Repayments of finance leases
negative 3,317,000 US dollars
Cash related to stock repurchases and retirements
negative 50,688,000 US dollars
Members' contributions
1,405,000 US dollars
Members' distributions
negative 28,620,000 US dollars
Proceeds from exercise of warrants
75,000 US dollars
Operating adjustment reconciliation
91,721,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
86,220,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
3,741,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Difference in the filed cash totals (calculated)
297,000 US dollars. Into cash; drawn as the small gray flow above beginning cash.
Ending cash on Jun 30, 2026
207,108,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
295,589,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
21,534,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.69×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
109,718,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
3,741,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
105,977,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $109.72M of net income directly to operating cash and $49.36M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • The filer's reported cash figures differ by $297.00 K: its ending cash less its beginning cash does not equal its reported net change in cash. The chart shows the difference as its own calculated flow; no reported amount has been adjusted.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 109,718,000 US dollars minus 3,741,000 US dollars equals 105,977,000 US dollars.
  • The filer's reported cash figures differ by $297.00 K: its ending cash less its beginning cash does not equal its reported net change in cash. The chart shows the difference as its own calculated flow; no reported amount has been adjusted.
NUTEX HEALTH INC. (NUTX) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!